From the Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA.
Yale Institute for Global Health.
Pediatr Infect Dis J. 2020 Jul;39(7):641-644. doi: 10.1097/INF.0000000000002629.
This analysis includes pooled data from 2 placebo-controlled maternal influenza immunization trials, with a separate analysis on a meningococcal conjugate vaccine-controlled maternal influenza immunization trial. Maternal influenza immunization was not associated with infant or maternal all-cause mortality in placebo-controlled trials. In the meningococcal conjugate vaccine-controlled trial, there were fewer deaths during low or any influenza circulation weeks among infants whose mothers received meningococcal conjugate vaccine. ClinicalTrials.gov identifiers: NCT01430689, NCT01034254 and NCT02465190.
本分析包括 2 项安慰剂对照的母亲流感免疫接种试验的汇总数据,以及一项脑膜炎球菌结合疫苗对照的母亲流感免疫接种试验的单独分析。安慰剂对照试验中,母亲流感免疫接种与婴儿或母亲全因死亡率无关。在脑膜炎球菌结合疫苗对照试验中,母亲接种脑膜炎球菌结合疫苗的婴儿在流感低流行或任何流行周的死亡人数更少。ClinicalTrials.gov 标识符:NCT01430689、NCT01034254 和 NCT02465190。